Publications

Optimal chemotherapy dosing in a bilateral lower extremities amputee with metastatic pancreatic adenocarcinoma

D Owen, EM O'Reilly, C Ang, J Ma, RKG Do, GK Abou-Alfa

Postoperative outcomes following pancreaticoduodenectomy: how should age affect clinical practice?

W Faraj, R Alameddine, D Mukherji, K Musallam, A Haydar, M ELoubiedi, ...

PREVALENCE OF HEREDITARY METABOLIC DISEASES IN THE IRISH TRAVELLER POPULATION

O Lam, E Crushell, I Knerr, E O'Reilly, J Hughes, A Monavari, EP Treacy

Prognosis of minimally invasive carcinoma arising in mucinous cystic neoplasms of the pancreas

GH Lewis, H Wang, AM Bellizzi, AP Klein, FB Askin, LE Schwartz, ...

Randomized phase II study of gemcitabine (G), cisplatin (C) with or without veliparib (V)(arms A, B) and a phase II single-arm study of single-agent veliparib (arm C) in …

EM O'Reilly, MA Lowery, KH Yu, M Capanu, ZK Stadler, AS Epstein, ...

Sunitinib malate for the treatment of pancreas malignancies–where does it fit?

P Mankal, E O'Reilly

The management of metastatic pancreatic cancer: expert discussion and recommendations from the 14th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2012

C Verslype, E Van Cutsem, M Dicato, N Arber, JD Berlin, MW Büchler, ...

Use of pharmacogenomic modeling in pancreatic cancer for prediction of chemotherapy response and resistance.

V Sangar, M Ricigliano, EM O'Reilly, GK Abou-Alfa, MA Lowery, L Saltz, ...

Use of pharmacogenomic modeling in pancreatic cancer for prediction of chemotherapy response and resistance.

KH Yu, V Sangar, M Ricigliano, M Hidalgo, GK Abou-Alfa, MA Lowery, ...

289 Assessment of a DNA-PK Inhibitor as a Chemo-potentiating Agent in Osteosarcoma

E O'Reilly, B Vormoor, S Kyle, H Newell

A 71-Year-Old Man with a Large Cystic Pancreatic Mass

D Mukherji, W Faraj, M Khalife, A Shamseddine, N El Majzoub, G Zaatari, ...

A 72-Year-Old Man With Duodenal Adenocarcinoma

S Tamraz, A Shamseddine, M Shah, M El-Oubeidi, G Zaatari, F Geara, ...

A case of advanced gastric cancer

C Ang, YY Janjigian, A Shamseddine, A Tawil, MA Lowery, A Intlekofer, ...

A case of synchronous pancreatic ductal adenocarcinoma and ovarian mucinous cystic neoplasm: use of kras mutation molecular phenotyping to demonstrate independent primary origin

M Lowery, D Klimstra, C Hedvat, W Jarnagin, D Chi, EM O'Reilly

A comparative analysis of locoregional therapy (hyperthermic intraperitoneal chemotherapy [HIPEC]) and systemic chemotherapy (CT) following cytoreductive surgery in patients …

TS Bekaii-Saab, LK Martin, GD Vallabhaneni, W Park, CA Staley, ...

A dual-targeting antibody against EGFR-VEGF for lung and head and neck cancer treatment

Zhang H, Yun S, Batuwangala TD, Steward M, Holmes SD, Pan L, Tighiouart M, Shin HJ, et al.

A Loss of Function Genetic Screen Identifies Determinants of Sensitivity to PARP Inhibitor ABT-888 in Pancreatic Cancer

W Park, BG Pantazides, BF El-Rayes, JW Shelton, DS Yu, JC Landry

A man with Klinefelter’s syndrome and new abdominal distension: a discussion of evaluation and management

M Postow, MA Shah, M Lowery, A Shamseddine, A El-Kutoubi, ...

A nonrandomized, phase II study of sequential irinotecan and flavopiridol in patients with advanced hepatocellular carcinoma

C Ang, EM O'Reilly, RD Carvajal, M Capanu, M Gonen, L Doyle, ...

A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers

JM Winter, LH Tang, DS Klimstra, MF Brennan, JR Brody, FG Rocha, X Jia, ...

A randomized trial of a cardiopulmonary resuscitation (CPR) video (V) in advance care planning (ACP) for progressive hepatopancreaticobiliary cancer patients.

AS Epstein, AE Volandes, K Gary, LY Chen, Y Li, P Agre, T Levin, ...

A synthetic lethal screen identifies genetic determinants for gemcitabine sensitivity in pancreatic cancer

JC Landry, BG Pantazides, W Park, JW Shelton, SK Maithel, B El-Rayes, ...

Activity of front-line FOLFIRINOX (FFX) in stage III/IV pancreatic adenocarcinoma (PC) at Memorial Sloan-Kettering Cancer Center (MSKCC).

MA Lowery, KH Yu, NG Adel, AJ Apollo, MS Boyar, P Caron, D Ilson, ...

Analysis of incidence and clinical outcomes in patients with thromboembolic events and invasive exocrine pancreatic cancer

AS Epstein, GA Soff, M Capanu, C Crosbie, MA Shah, DP Kelsen, ...

Association between skin toxicities and treatment outcomes in patients with pancreatic cancer (PC) receiving erlotinib (E): Memorial Sloan-Kettering Cancer Center (MSKCC …

LM Alejandro, NG Adel, EM O'Reilly, E Riedel, ME Lacouture

Augmenting advance care planning in poor prognosis cancer with a video decision aid: a preintervention‐postintervention study

AE Volandes, TT Levin, S Slovin, RD Carvajal, EM O'Reilly, ML Keohan, ...

Autophagic cell death induced by curcumin is mediated by p38/Beclin 1 to crosstalk with apoptotic cell death in DU145 cells

D Kang, W Park, JH Kim, JJ Song

Clinicopathologic feature and outcome of appendiceal goblet cell carcinoid and neuroendocrine tumor.

W Park, GD Vallabhaneni, LK Martin, V Adsay, CA Staley, SK Maithel, ...

Communication and palliative care in a 64-year-old man with pancreatic adenocarcinoma

AS Epstein, GK Abou-Alfa, A Shamseddine, A Al-Olayan, C Ang, M Naghy, ...

Costs and trends in pancreatic cancer treatment

CB O'Neill, CL Atoria, EM O'Reilly, J LaFemina, MC Henman, EB Elkin

DNA Resection and Chromatin Remodeling in G1 Checkpoint Activation of Budding Yeast

FO Balogun

Downstaging in pancreatic cancer: a matched analysis of patients resected following systemic treatment of initially locally unresectable disease

KA Bickenbach, M Gonen, LH Tang, E O’Reilly, K Goodman, MF Brennan, ...

Early postoperative intraperitoneal chemotherapy following cytoreductive surgery for appendiceal mucinous neoplasms with isolated peritoneal metastasis

PL Wagner, D Jones, A Aronova, J Shia, MR Weiser, LK Temple, ...

Exocrine pancreas cancer and thromboembolic events: a systematic literature review

AS Epstein, EM O'Reilly

Functional inhibition of HSP90 potentiates the effects of ionizing radiation in colorectal cancer

GP Nagaraju, J Wen, BF El-Rayes, JC Landry, W Park, R Diaz

Ganetespib, an HSP90 Inhibitor, Sensitizes Colorectal Cancers to the Effects of Ionizing Radiation

R Diaz, GP Nagaraju, W Park, BF El-Rayes, JC Landry

Gastrointestinal Cancer Educatinal Case Series: A 65 year-old Female with Locally Advanced Gastric Cancer and a Supraclavicular Lymph Node

EC Smyth, YJ Lee, G Abou-Alfa, S Seo, A Shamseddine, E O’Reilly, ...

Gemcitabine induced myositis in patients with pancreatic cancer: case reports and topic review

E Pentsova, A Liu, M Rosenblum, E O’Reilly, X Chen, A Hormigo

Genomics and pharmacogenomics of pancreatic adenocarcinoma

MA Lowery, EM O'reilly

Identification of potential prognostic biomarkers in patients with untreated, advanced pancreatic cancer from a phase 3 trial (Cancer and Leukemia Group B 80303)

AS Roberts, MJ Campa, EB Gottlin, C Jiang, K Owzar, HL Kindler, ...

Inhibition of poly (ADP-ribose) polymerase-1 (PARP-1) to increase radiosensitivity of human pancreatic cancer (PAC) cell lines proficient in homology-directed repair (HDR).

MA Lowery, F Vanoli, KH Yu, M Jasin, EM O'Reilly, ME Moynahan

Management of a Locally Advanced Rectal Cancer in a Patient Who Declined Surgery

R Alameddine, D Wehbe, M Weiser, N Segal, K Goodman, ...

Neoadjuvant Therapy in Clinical Stage II Pancreatic Adenocarcinoma

A Snyder, P Allen, A Shamseddine, A Haydar, M Eloubeidi, W Faraj, ...

Phase II study of ganetespib, an hsp-90 inhibitor, in patients with refractory metastatic colorectal cancer.

A Cercek, J Shia, M Gollub, PJ Raasch, E Hollywood, DL Reidy, ...

Postresection surveillance for pancreatic cancer performance status, imaging, and serum markers

EM O’Reilly, MA Lowery

Retrospective review of doxorubicin plus sorafenib as second-line therapy in hepatocellular carcinoma (HCC).

GK Abou-Alfa, J Ma, EM O'Reilly, B Gansukh, JF Chou, M Capanu, L Saltz

Targeted agents and systemic therapy in hepatocellular carcinoma

C Ang, EM O’Reilly, GK Abou-Alfa

Unusual DNA mismatch repair–deficient tumors in Lynch syndrome: a report of new cases and review of the literature

MDY Karamurzin, MDZ Zeng, MDZK Stadler, MDL Zhang, MDI Ouansafi, ...

Use of EGF A61G polymorphism to predict overall survival in a phase III study of gemcitabine plus cetuximab versus gemcitabine in patients with locally advanced or metastatic …

MJ Labonte, BH Goldman, W Zhang, CD Blanke, PA Philip, R Wong, ...

Using video in advance care planning for progressive pancreas and hepatobiliary cancer patients

AS Epstein, AE Volandes, EM O'Reilly